Diindolylmethane in Treating Patients With Abnormal Cervical Cells

Last updated: August 6, 2013
Sponsor: Barts and the London School of Medicine and Dentistry
Overall Status: Completed

Phase

3

Condition

Cervical Cancer

Dysfunctional Uterine Bleeding

Vaginal Cancer

Treatment

N/A

Clinical Study ID

NCT00462813
CRUK-CRISP-1
ISRCTN47437431
EU-20717
CDR0000539352
  • Female

Study Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of diindolylmethane, a substance found in cruciferous vegetables, may keep cervical intraepithelial neoplasia or cervical cancer from forming.

PURPOSE: This randomized phase III trial is studying diindolylmethane to see how well it works compared to a placebo in treating patients with abnormal cervical cells.

Eligibility Criteria

Inclusion

DISEASE CHARACTERISTICS:

  • First mildly dyskaryotic Pap smear or a second borderline Pap smear taken within the Cervical Screening Wales program

  • Patients under surveillance following treatment for high-grade cervical intraepithelial neoplasia are not eligible

  • No clinical suspicion of a concurrent invasive cervical cancer

PATIENT CHARACTERISTICS:

  • No invasive cancer within the past 3 years

  • No known HIV positivity

  • Not pregnant or nursing

  • Not planning to become pregnant within the next 6 months

PRIOR CONCURRENT THERAPY:

  • No concurrent immunosuppressive drugs, warfarin, or theophylline

  • No concurrent proton pump inhibitor drugs for ulcer or reflux disease (i.e., rabeprazole, esomeprazole magnesium, lansoprazole, omeprazole, or pantoprazole sodium)

Study Design

Total Participants: 3000
Study Start date:
October 01, 2004
Estimated Completion Date:
January 31, 2010

Study Description

OBJECTIVES:

  • Compare the effect of diindolylmethane vs placebo in reducing the prevalence of histologically proven high-grade cervical intraepithelial neoplasia in patients with low-grade cervical cytological abnormalities.

  • Compare the effect of these regimens in reducing the prevalence of cytological abnormalities in these patients.

  • Compare the effect of these regimens in changing the clinical appearance of the cervix in these patients.

  • Determine if diindolylmethane offers benefits in relation to human papillomavirus (HPV) status, including HPV type, viral load, and integration.

  • Determine the side effects of supplementation with diindolylmethane.

  • Determine the effects of this drug on migraine, mastalgia, weight, and premenstrual syndrome (PMS).

OUTLINE: This is a double-blind, randomized, placebo-controlled, multicenter study. Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients receive oral diindolylmethane once daily for 6 months.

  • Arm II: Patients receive oral placebo once daily for 6 months. Patients undergo cervical sampling at baseline and at 6 months for Pap testing by liquid based cytology and human papillomavirus (HPV) testing by polymerase chain reaction. Some patients also undergo urine and hair sample collection at baseline and at 3 and 6 months. Samples are analyzed for estrogen and diindolylmethane metabolites, to monitor patient compliance and response to treatment. Some patients have a cervical photograph taken using a colposcope at baseline and at 6 months. All patients undergo colposcopy at 6 months.

Patients complete a questionnaire at baseline (i.e., for reproductive history, diet, smoking, and premenstrual symptoms) and at 6 months (i.e., for side effects, compliance, changes in smoking, and contraception use). Patients with moderate to severe premenstrual syndrome (PMS) also complete PMS questionnaires once monthly during months 1-6 and 4 months following completion of study therapy. All patients are instructed to maintain current diet and to keep cruciferous vegetables and soy products constant during study course.

After completion of study treatment, patients are followed periodically for up to 7 years.

PROJECTED ACCRUAL: A total of 3,000 patients will be accrued for this study.

Connect with a study center

  • Barts and the London School of Medicine

    London, England EC1M 6BQ
    United Kingdom

    Site Not Available

  • University Hospital of Wales

    Cardiff, Wales CF14 4XW
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.